160 related articles for article (PubMed ID: 19077774)
1. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes.
Tibaldi J
South Med J; 2009 Jan; 102(1):60-6. PubMed ID: 19077774
[TBL] [Abstract][Full Text] [Related]
2. Importance of postprandial glucose control.
Bell DS
South Med J; 2001 Aug; 94(8):804-9. PubMed ID: 11549192
[TBL] [Abstract][Full Text] [Related]
3. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
Robertson C
Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
[TBL] [Abstract][Full Text] [Related]
4. [Importance of daily glycemic variability in achieving glycemic targets in type 2 diabetes: role of DPP-4 inhibitors].
Ampudia-Blasco FJ; Ceriello A
Med Clin (Barc); 2010 Sep; 135 Suppl 2():33-9. PubMed ID: 21420536
[TBL] [Abstract][Full Text] [Related]
5. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
Shaefer CF; Anderson J
Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
[TBL] [Abstract][Full Text] [Related]
6. Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes.
Aronoff SL
Postgrad Med; 2017 Mar; 129(2):231-241. PubMed ID: 28118069
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
Fonseca V
Curr Med Res Opin; 2003; 19(7):635-41. PubMed ID: 14606987
[TBL] [Abstract][Full Text] [Related]
8. Targeting prandial hyperglycemia: how important is it and how best to do this?
Monnier L; Colette C
Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585
[TBL] [Abstract][Full Text] [Related]
9. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
Flint A; Kapitza C; Hindsberger C; Zdravkovic M
Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
[TBL] [Abstract][Full Text] [Related]
10. Control of postprandial glucose levels with insulin in type 2 diabetes.
Blevins T
Postgrad Med; 2011 Jul; 123(4):135-47. PubMed ID: 21680998
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 based therapies: differential effects on fasting and postprandial glucose.
Fineman MS; Cirincione BB; Maggs D; Diamant M
Diabetes Obes Metab; 2012 Aug; 14(8):675-88. PubMed ID: 22233527
[TBL] [Abstract][Full Text] [Related]
12. Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs.
Freeman JS
J Am Osteopath Assoc; 2010 Sep; 110(9):528-37. PubMed ID: 20876838
[TBL] [Abstract][Full Text] [Related]
13. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.
Yacoub T
Postgrad Med; 2017 Nov; 129(8):791-800. PubMed ID: 29032696
[TBL] [Abstract][Full Text] [Related]
14. Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
Aoki K; Kamiyama H; Yoshimura K; Shibuya M; Masuda K; Terauchi Y
Acta Diabetol; 2012 Jun; 49(3):225-30. PubMed ID: 21898126
[TBL] [Abstract][Full Text] [Related]
15. When oral agents fail: optimizing insulin therapy in the older adult.
Meece J
Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
[TBL] [Abstract][Full Text] [Related]
16. The effect of short-term glycemic regulation with gliclazide and metformin on postprandial lipemia.
Emral R; Köseoğlulari O; Tonyukuk V; Uysal AR; Kamel N; Corapçioğlu D
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):80-4. PubMed ID: 15772898
[TBL] [Abstract][Full Text] [Related]
17. [Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics].
Gao Y; Pan CY; Zou DJ; Xu ZR; Liu XM; Guo XH
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1960-3. PubMed ID: 19950569
[TBL] [Abstract][Full Text] [Related]
18. Postprandial plasma glucose effects of once-weekly albiglutide for the treatment of type 2 diabetes.
Matthews JE; Reinhardt RR; Carr MC
Postgrad Med; 2016 May; 128(4):391-7. PubMed ID: 27043162
[TBL] [Abstract][Full Text] [Related]
19. How should postprandial glycemia be treated?
Charpentier G; Dardari D; Riveline JP
Diabetes Metab; 2006 Sep; 32 Spec No2():2S21-7. PubMed ID: 17375403
[TBL] [Abstract][Full Text] [Related]
20. Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
Umpierrez GE; Bailey TS; Carcia D; Shaefer C; Shubrook JH; Skolnik N
J Diabetes; 2018 Feb; 10(2):94-111. PubMed ID: 28581207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
